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Abstract
Background: In order to maintain cellular viability and genetic integrity cells must respond quickly following the
induction of cytotoxic double strand DNA breaks (DSB). This response requires a number of processes including
stabilisation of the DSB, signalling of the break and repair. It is becoming increasingly apparent that one key step
in this process is chromatin remodelling.
Results: Here we describe the chromodomain helicase DNA-binding protein (CHD4) as a target of ATM kinase. We
show that ionising radiation (IR)-induced phosphorylation of CHD4 affects its intranuclear organization resulting in
increased chromatin binding/retention. We also show assembly of phosphorylated CHD4 foci at sites of DNA
damage, which might be required to fulfil its function in the regulation of DNA repair. Consistent with this, cells
overexpressing a phospho-mutant version of CHD4 that cannot be phosphorylated by ATM fail to show enhanced
chromatin retention after DSBs and display high rates of spontaneous damage.
Conclusion: These results provide insight into how CHD4 phosphorylation might be required to remodel
chromatin around DNA breaks allowing efficient DNA repair to occur.
Introduction
It is essential that human cells detect, signal and repair
DNA damage in order to prevent chromosomal instabil-
ity or malignant transformation. DNA double strand
breaks can be induced by a number of agents including
ionising radiation (IR), reactive chemical species and
during endogenous DNA processing events such as
DNA replication [1]. These breaks must be repaired in
order to maintain cellular viability and genomic stability.
Once a break has occurred, cells respond by recruiting
DNA repair proteins to the DSB sites and initiate a
complex DSB response pathway, which includes altered
transcriptional and translational regulation, activation of
DSB repair and cell cycle checkpoint arrest.
It is clear that chromatin restructuring in response to
DNA damage is essential for initiation, propagation and
termination of DNA repair and may even precede DNA
end resection. This process opens the DNA allowing the
recruitment of repair factors and the amplification of
the checkpoint and downstream signals [2]. Consistent
with this, the DNA damage response can be activated in
the absence of exogenous DNA damage by the tethering
of DNA damage response proteins to chromatin,
demonstrating the importance of chromatin as a scaffold
in the activation and amplification of the DNA damage
response. In mammalian cells, the accumulation of any
one of early response proteins MDC1, Mre11, Nbs1 or
ATM is sufficient to achieve checkpoint activation [2].
This work extends the seminal discovery by Bakkenist
and Kastan [3] that changes in chromatin structure can
lead to ATM activation [3]. Whether ATM directly
senses the disturbance in chromatin structure or
requires an unidentified DSB sensor to transmit the sig-
nal is thus far unclear. Nonetheless, ATM kinase activity
is a primary driving force for chromatin alterations ema-
nating from DSB induction. Emerging evidence suggests
that rapid IR-induced phosphorylation of H2AX and
MDC1 by ATM serves as a recruiting signal for E3 ubi-
quitin ligase RNF8 [4-7]. RNF8 acts together with
RNF168 to ubiquitinate histone H2AX and other chro-
matin proteins in the vicinity of the break [8-10]. The
combined activity of these ligases is required for produc-
tive recruitment of repair proteins including 53BP1 and
BRCA1. Notably, histone ubiquitination on chromatin
surrounding the DSBs has recently been shown to
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mediate RNF8 and RNF168 dependent tra!nscription
repression, which suggests the existence of cross talk
between cellular processes mediated by these post-trans-
lational modifications [11].
CHD4 is a ≈210kDa protein that is highly conserved
throughout the animal and plant kingdoms. The protein is
composed of a PHD finger, two chromodomains and a
C-terminal ATPase domain [12] and a putative C-terminal
nuclear localisation signal (NLS) domain [13] (Figure 1a).
The C-terminal ATPase/SNF-like helicase domain
provides the energy required for histone displacement
during nucleosome remodelling. Interestingly unlike
other chromodomains that bind to histone marks,
CHD4 has the unusual activity of binding directly to
DNA [14]. CHD4 is a member of the class two family
of CHD ATPases and is known to be a major subunit
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Figure 1 CHD4 interacts with the DNA damage response kinase ATM. (A) A schematic representation of the CHD4 protein, NLS; the
putative nuclear localisation signal, PHD; plant homeodomain, Chromo; chromodomain, helicase and ATPase domain region. (B, C) ATM
proficient C3ABR cells either mock irradiated or irradiated with 6Gy IR, 1hr after IR cell lysates were prepared and immunoprecipitated with for
ATM, CHD4 or mock (IgG). The indicated proteins were subjected to western blot analysis. (D) Cell lysates prepared from C3ABR cells were
subjected to pulldown assays using purified GST-CHD4 fusion protein fragments spanning the full length of CHD4. Upper Panel: ATM western
blot of GST-CHD4 fusion fragment pulldown. Lower Panel: Coomassie stain of GST-CHD4 fusion fragments following SDS-PAGE. (E) ATM western
blot following a GST-CHD4 fragment 7 pulldown or GST alone (NS) pulldown from L3 (ATM deficient) or C3ABR (ATM proficient) cell lysates.
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of the NuRD (nucleosomal remodelling and deacetylase)
complex [15]. This complex has a number of enzymatic
activities including chromatin remodelling, histone dea-
cetylase and demethylase functions [13,15-19]. The loss
of components of NURD complex leads to accumula-
tion of ageing related chromatin defects [16]. Two
recent publications have implicated CHD4 in the DNA
damage response; specifically CHD4 depletion disrupts
the chromatin response at the level of RNF168, prevent-
ing BRCA1 assembly [17,19]. CHD4 also functions as an
important regulator of the G1/S transition by control-
ling p53 deacetylation as well as Cdc25A and p21Cip1
stability [13,17]. This clearly implicates CHD4 as a
novel chromatin-remodeling factor required for chro-
mosomal stability.
Here we describe how CHD4 functions directly in the
processes required for the efficient repair of DSBs. Our
data demonstrates that CHD4 is phosphorylated rapidly
at Ser-1349 by ATM following induction of DSBs and
that this phosphoryated CHD4 is specifically located at
sites of DSBs. We also demonstrate that the CHD4 Ser-
1349 phosphorylation is required for the CHD4 chroma-
tin retention and for the efficient repair of DSBs.
Experimental procedures
Cell culture, plasmids, siRNA and antibodies
Human cell lines 293T, HeLa, CaCo2, U2OS, C3ABR,
L3 and Seckle cells were maintained in RPMI 1640
medium supplemented with 10% foetal calf serum and
incubated at 37°C with 5% CO2. Transfection of plas-
mids and siRNA was performed using Lipofectamine
2000 (Invitrogen) as per manufacturer’s instructions.
A series of GST-CHD4 constructs were generated, which
together spanned the full length of CHD4. These
constructs corresponding to F1 (1-1106), F2 (308-1307),
F3 (930-1584), F4 (1528-2511), F5 (2109-3111), F6
(2802-3815), F7 (3666-4521), F8 (4000-5037) and F9
(4431-5037) were PCR amplified and then cloned into
the GST-5x-3 vector (GE Healthcare) for expression.
GST-CHD4 fusion proteins were purified as described
previously [18]. Full length Flag-CHD4 plasmid was a
kind gift from Yi Zhang. The Flag-CHD4 S1349A mutant
was prepared by site-directed mutagenesis using the
Quikchange mutagenesis kit (Stratagene) according to
manufacturers instructions. RNA interference was per-
formed using 5’-CAGUUACCAAGAAGACUUAdTdT-3’
siRNA specific to CHD4 or control 5’UUCUCCGAAC-
GUGUCACGUdTdT-3’ siRNA. The siRNA sequences
were synthesized as duplexes (Invitrogen).
Antibodies used in this study were supplied by: Cell
Signaling (53BP1, Chk1 S317, p53 S15, ATM S1981),
Oncogene (Brca2), Upstate (Acetyl-Lys-H4), Millipore
(H2AX), Sigma (FLAG), Santa Cruz (p53, Chk1) Gene-
Tex (ATM), anti-ATM AT9 for immunoprecipitation
analysis was prepared in house [20]. The CHD4 anti-
body was a kind gift from Wei Dong. Rabbit polyclonal
anti-phosphopeptide antisera against CHD4 (Serine
1349) was raised using the synthetic peptide NYNDG
phospho-SQEDRDW-NH2 conjugated to keyhole limpet
hemocyanin (KLH) at the Institute of Medical and
Veterinary Sciences, Adelaide, Australia.
Immunoblotting and Immunoprecipitation
Cells were harvested in PBS and cell extracts were pre-
pared by lysis in universal immunoprecipitation buffer
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA,
25 mM sodium fluoride, 25 mM b-glycerophsphate, 0.1
mM sodium orthovanadate, 0.1 mM phenylmethysulfo-
nyl fluoride, 0.2% Triton-X 100, 0.3% Igepal CA-630, 0.5
mM dithiothreitol, protease inhibitor cocktail (Sigma))
and incubated on ice for 30 min and then sonicated
with a Barnson Sonifier 450. Supernatants were col-
lected following centrifugation at 14,000 × g for
15 mins. 25 μg of protein sample was then analysed by
SDS- polyacrylamide gel electrophoresis and immuno-
blotting with appropriate antibodies. For co-immunopre-
cipitations protein samples were pre-cleared with
protein A beads for 1 hr at 4°C. The supernatants were
then incubated with the appropriate antibody for 2 hr.
The immune complexes were collected with protein A
and protein G beads. The complexes were washed twice
with lysis buffer and then fractionated by SDS-polyacry-
lamide gel electrophoresis for immunoblot analysis. For
protein pull-down assays, protein samples were pre-
cleared with Glutathione Sepharose beads for 1hr at
4°C. The supernatants were then incubated with purified
GST fusion protein fragments linked to Glutathione
Sepharose beads for 2 hr. The complexes were washed
twice with lysis buffer and then fractionated by SDS-
polyacrylamide gel electrophoresis for immunoblot
analysis.
Chromatin Fractionation was undertaken using a
Sub-cellular Protein Fractionation Kit (Thermo Scientific
Cat# 78840) as per manufacturer’s instructions.
Kinase Assays
Cells were harvested in PBS and cell extracts were
prepared by lysis in TGN buffer (50 mM Tris-HCl, pH
7.5, 50 mM b-glycerophsphate, 150 mM NaCl, 10% gly-
cerol, 1% Tween 20, 1 mM NaF, 1 mM sodium orthova-
nadate, 1 mM phenylmethysulfonyl fluoride, 2 μg/ml
pepstatin, 10 μg/ml aprotinin, 5 μg/ml leupeptin and 1
mM dithiothreitol) as described previously [21]. The
immunoprecipitation was carried out as described above
using an anti-ATM antibody. The immunoprecipitates
were washed twice with TGN buffer, once with 100 mM
Tris-HCl (pH 7.5) and 0.5 M LiCl, and twice with kinase
buffer (10 mM Hepes, pH 7.5, 50 mM b-glyceropho-
sphate, 50 mM NaCl, 10 mM MgCl2, 10 mM MnCl2,
5 mM ATP, and 1 mM dithiothreitol). Kinase reactions
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were prepared by resuspending washed beads in 30 μl of
kinase buffer containing 10 μCi of [g-32P] ATP and 1 μg
of GST-CHD4 fusion protein. Immune complex reac-
tions were incubated at 30°C for 30 min and analyzed
by SDS-polyacrylamide gel electrophoresis followed by
autoradiography.
Immunofluorescence was performed as described pre-
viously [18]. Briefly, cells grown on glass coverslips or on
Ibidi 8 well μ-slides were washed with PBS, treated for
5 min with Triton buffer (0.5% Triton X-100 in 20 mM
Hepes, pH 7.4, 50 mM NaCl, 3 mM MgCl2, and 300 mM
sucrose) on ice to remove soluble proteins. Cells with the
remaining chromatin-bound proteins were fixed with
PBS-buffered 4% paraformaldehyde in 2% sucrose solu-
tion at room temperature for 10 min. Fixed cells were
washed 3 times with TBS-T (25 mM Tris-HCl [pH 7.5],
150 mM NaCl, 0.1% Tween 20) and blocked in 3% BSA
in TBS-T buffer for 30 min. Cells were then incubated
with an appropriate primary antibody in blocking buffer
at 4°C overnight. After washing three times in blocking
buffer cells were incubated with the appropriate second-
ary antibody (Alexa 488 or Alexa 546, Invitrogen). Images
were taken on a Deltavision PDV microscope or GE
Healthcare In Cell Analyzer 2000.
In-nuclear-western
These assays were performed as described previously
[22], using the GE Healthcare In Cell Analyzer 2000 and
the data analysed using In Cell Investigator software.
Assays were performed using GE Healthcare 96 well
Matriplates. Immunofluorescence was performed as
described above. The In Cell Analyser automatically
counted 300 cells from each well prior to measuring the
mean nuclear intensity for each signal (Alexa 488).
Results
CHD4 interacts with the ATM kinase
We originally identified CHD4 as an ATM interacting
protein during co-precipitation (co-IP) experiments of
GFP-tagged ATM and Flag-tagged CRM1. We consis-
tently noticed an additional cross-reacting (Flag-
antibody) band of ~200KDa in a GFP-ATM IP from
irradiated cells. Bioinformatic analysis of proteins of
similar size, in database, that show sequence similarity
to Flag-epitope, identified CHD4 as a possible candi-
date. To confirm this initial observation we precipi-
tated ATM from HeLa cellular extract before and after
the induction of DSBs by IR (6 Gy) and blotted the
immunoprecipitates with anti-CHD4 antibody. This
confirmed that IR stimulated the interaction between
ATM and CHD4 (Figure 1b). We also performed the
reciprocal co-immunoprecipitation using CHD4 anti-
body followed by immunoblotting with anti-ATM and
this also demonstrated that both proteins interacted
(Figure 1c).
CHD4 is phosphorylated by the ATM kinase
ATM is the apical kinase responsible for the initiation
of cellular signaling following induction of DSBs [23]. It
functions to phosphorylate a number of downstream
substrates including p53, Chk2 and hSSB1 [24-26]. We
initially mapped the ATM binding site on CHD4 using
GST fusion fragments that span the full-length of
CHD4. GST-CHD4 fragments bound to glutathione
agarose were used to precipitate ATM from cellular
extract [26]. We observed that CHD4 fragment 7
(representing amino acids 1222-1507) precipitated ATM
from HeLa cellular lysates (Figure 1d). GST-pull down
experiment with this fragment using cellular extracts
from ATM-deficient (L3) and control (C3ABR) lympho-
blastoid cells confirmed that the band detected in
immunoblot was indeed ATM (Figure 1e). We next
decided to determine if CHD4 is a substrate of the
ATM kinase since it contains 8 consensus sites of phos-
phorylation by ATM (SQ/TQ). Using immunoprecipi-
tated ATM kinase and the purified GST-CHD4
fragments as substrates we observed that phosphoryla-
tion of three C-terminal CHD4 fragments (Fragments
7-9) was induced after IR (Figure 2a). Furthermore,
ATM immunoprecipitated from irradiated control
(C3ABR) cells phosphorylated these fragments whereas
immunoprecipitates obtained from L3 (not expressing
ATM line, Figure 1e), failed to show any activity against
each of the GST-CHD4 fusion proteins tested (Figure 2b).
During this time, Ser-1349 in CHD4 was identified as
an ATM phosphorylation site in a extensive phospho-
proteomic screen of proteins precipitated by ATM
phosphosite antibodies [27]. Of the three GST-CHD4 frag-
ments phosphorylated by ATM in this study, Fragment 7
and 8 contain this phosphorylation site due to presence of
overlapp!ing sequence between them. Next we raised
phospho-specific antibody against Ser-1349 phosphory-
lated CHD4 peptide to monitor this phosphorylation
event in vivo in cells. To confirm specificity of this anti-
body we immunoblotted control or CHD4 depleted U2OS
extracts (using specific siRNAs) with or without prior
exposure to IR (6 Gy) with antiphospho-specific antibody.
CHD4 was found to be markedly phosphorylated in irra-
diated cell extracts from control siRNA transfected cell
and this signal was diminished in CHD4-depleted cells
(Figure 2c). This observed increase in IR-induced CHD4
phospho-Ser 1349 reactivity was also observed in HeLa
and CaCO2 cell lines (Figure 2d). To confirm this was
an ATM specific phosphorylation event we immuno-
blotted extract prepared from ATM-proficient (C3ABR),
ATM-deficient (L3) and ATR- deficient (Seckle) cell lines
with or without prior exposure to IR. While rapid IR-
induced phospho-reactivity was observed in the C3ABR
cells we were unable to observe induction in the L3 cells,
which does not express ATM protein (Figure 2e),
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suggesting that this phosphorylation event was ATM
specific. We also observed normal IR-induced CHD4
Ser-1349 phosphorylation in extracts from ATR-deficient
Seckel cells. These observations confirm that ATM cata-
lyzes rapid IR-induced phosphorylation of CHD4 on
Ser-1349.
ATM phosphorylated CHD4 (Ser1349) colocalises
with gH2AX
To explore the involvement of CHD4 in the DSB repair
process we examined the nuclear distribution of CHD4
prior to and after treatment with IR. We were unable to
observe any difference in the normal pan nuclear
Figure 2 CHD4 is phosphorylated in an ATM-dependent manner at Ser1349 following DNA damage. (A) C3ABR cells were either mock
irradiated or treated with 10Gy IR, 1hr after treatment cell lysates were prepared, immunoprecipitated for ATM and then an ATM kinase assay
was performed against GST-CHD4 fusion protein fragments as indicated. (B) ATM proficient (C3ABR) and ATM deficient (L3) cells were irradiated
with 10Gy IR, 1hr after IR cell lysates were prepared and immunoprecipitated for ATM and an ATM kinase assay was then performed against 1
μg of purified GST-CHD4 fusion protein fragments as indicated. (C) Mock (siControl) depleted or CHD4 depleted (siCHD4) U2OS cells were either
untreated or treated with 6Gy IR, 1hr after IR cell lysates were prepared and subjected to western blot analysis for CHD4S1349 and CHD4 as
indicated. (D) Hela cells and CaCO2 cells were either untreated or treated with 6Gy IR, 1hr after IR cell lysates were prepared and subjected to
western blot analysis for CHD4S1349 and CHD4 as indicated. (E) ATM proficient (C3ABR) cells, ATM deficient (L3) cells and ATR deficient (Seckle)
cells were either untreated or treated with 6Gy IR, cell lysates were then prepared at 30 min and 1hr after IR or from unirradiated cells. The
lysates were then subjected to western blot analysis as indicated.
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distribution of CHD4 following IR after staining with
antibody that recognizes the total pool of CHD4 in cells
(data not shown). Notably, using anti-phosphospecific
CHD4 antibody (anti-Ser 1349), we found that phos-
phorylated CHD4 rapidly formed IR-induced (2 Gy)
nuclear foci, which were found to co-localise with
gH2AX, a known marker of sites of DSBs following IR
(Figure 3a). This suggested that CHD4 is either specifi-
cally phosphorylated at these sites within the nucleus or
that phosphorylated CHD4 re-distributes to these sites.
This staining was specific as CHD4-depleted cells
(Figure 3ab) showed a marked reduction in phosphory-
lated CHD4 nuclear foci. The depletion of CHD4, how-
ever, had no apparent effect on the gH2AX foci
induction 30 minutes following IR (Figure 3ab). These
results suggest that phosphorylated CHD4 may function
in the process of DSB repair. Following the induction of
DSBs, the MRN complex is recruited to the break sites
[28]. There it stimulates the ATM kinase and amplifies
downstream signaling [29]. Next, we determined the
impact of CHD4-depletion on ATM activation and
activity by assessing the autophosphorylation of ATM
and phosphorylation of its downstream substrates. We
were unable to observe any defect in rapid (1 hr after
IR) activation of ATM signaling (Figure 3c). This would
suggest that CHD4 is dispensable for the initial recruit-
ment of MRN or ATM activation. Indeed, we were
unable to observe any defect in Mre11 or Nbs1 recruit-
ment to DSB repair foci in CHD4 depleted cells
(siRNA) (data not shown).
The loss of chromatin remodeling has been shown to
perturb the normal kinetics of the DSB repair process
[22]. To examine if CHD4 regulates the normal proces-
sing of DSBs we determined the kinetics of loading of
two well-established markers of the DSB repair, gH2AX
and 53BP1 on to chromatin. Using in-nuclear-westerns
[22], to measure chromatin bound 53BP1 and gH2AX,
we observed that depletion of CHD4 (siRNA) resulted
in a more pronounced recruitment of 53BP1 to chroma-
tin (Figure 3de). The level of chromatin bound 53BP1
remained higher in the CHD4 depleted cells during the
course of the experiment. gH2AX also showed a more
rapid activation following IR; however, this was less
marked than was observed for 53BP1 (Figure 3de, f).
Interestingly, although ATM autophosphorylation
(S1981) and SMC1 phosphorylation (S957) occurs in a
timely manner in CHD4 depleted cells, these cells show
a more rapid loss of signal (Figure 3g). These results are
interesting as they demonstrate an abnormality in the
repair kinetics of CHD4-deficient cells. It is possible
that the loss of CHD4 function has a global effect on
chromatin structure, effecting overall DNA repair pro-
tein accessibility of these damage sites and also exposing
more DNA to damage. This could potentially result in
higher rates of spontaneous damage as more DNA is
exposed to the solute environment. However we failed
to observe an increase in markers for spontaneous
damage e.g. spontaneous gH2AX foci formation or
spontaneous activation of ATM/ATR signaling events in
CHD4-depleted cells. This may be due to technical lim-
itation in achieving a complete knockout of CHD4
expression or that areas of DNA damage are rapidly
repaired in these cells.
It is likely that depletion of CHD4 results in a relaxa-
tion of chromatin structure, which would affect the abil-
ity of proteins to access the DNA structure and would
also expose the DNA structure to the solute environ-
ment, causing DNA damaging events such as oxidation.
This would explain the higher levels of chromatin
bound 53BP1 and gH2AX observed following IR treat-
ment in the CHD4-depleted cells. To determine if there
was a global effect on chromatin structure in CHD4
depleted cells we used antibodies to euchromatin mar-
kers, Acetyl-lys-H3 and H4. These confirmed that there
was a significant and general increase in the level of
these markers in CHD4 depleted cells, indicating a
higher degree of euchromatin (Figure 4ab). Microarray
data of CHD4-deficient cells also indicated a global
change in transcription levels, with over 10% of genes
transcripts changing by >1.5 fold (1877 transcripts from
an array of 18000 (data not shown). Consistent with this
we observed cellular BRCA2 protein levels were elevated
by over 3 fold in CHD4 depleted cells (Figure 4c).
Importantly, increase in BRCA2 levels in CHD4-
depleted Hela cells was not an artifact of cell cycle
arrest, as this did not impact on normal cell cycle pro-
gression (data not shown).
CHD4 phosphorylation by ATM is required for its
recruitment to chromatin and the timely repair of DSBs
following IR
Many DNA damage repair proteins become more
strongly associated with chromatin following DNA
damage. Since we have now shown that CHD4 is phos-
phorylated by ATM we decided to explore the chroma-
tin association of CHD4 before and after DNA damage.
Interestingly, we see a tighter association of CHD4 with
chromatin following treatment with IR (Figure 5a). To
determine if this association was ATM-dependent, we
fractionated chromatin of ATM-proficient (C3ABR) and
ATM deficient (L3) cells with or without prior exposure
to radiation. While CHD4 loaded normally onto chro-
matin following IR treatment in ATM proficient cells,
we did not observe increased IR-induced CHD4 chro-
matin loading in ATM-deficient cells (Figure 5b). We
next decided to determine if damage-induced phosphor-
ylation of CHD4 on Ser-1349 was required for its chro-
matin loading. Following IR, overexpressed Flag-CHD4
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Figure 3 CHD4 depletion does not affect overall ATM DNA damage signalling following IR, but does enhance the magnitude and
duration of the DNA damage response. (A) CHD4S1349 and gH2AX co-staining in unirradiated or 1 hr following 2Gy IR, in mock (siControl)
and CHD4 depleted (siCHD4) HeLa cells. Dapi stained nuclei are shown in the merged image. Detergent pre-extraction was performed before
immunostaining. The enlarged image shows CHD4S1349 and gH2AX co-staining. (B) HeLa cells were treated with mock (siControl) or CHD4
depleted (siCHD4), after 48 h cell lysates were prepared and subjected to western blot analysis for CHD4 and DNAPK as indicated. (C) HeLa cells
were treated with mock (siControl) or CHD4 depleted (siCHD4). Cells were then treated with 10Gy IR or mock irradiated and cell lysates were
prepared after 1 h. The lysates were subjected to western blot analysis for ATM S1981, P53 S15, P53, Chk1 S315 and Chk1 as indicated. (D) In-
nuclear-western analysis of chromatin bound 53BP1 in mock (siControl) and CHD4 depleted (siCHD4) treated U2OS cells. Cells were treated with
4Gy IR or unirradiated (0 hr), at the indicated time points detergent pre-extraction was used to remove non-chromatin bound proteins prior to
fixation and immunofluorescence analysis. Mean fluorescence signal was then calculated from at least 300 cells. (E, F) In-nuclearwestern analysis
of chromatin bound gH2AX (E) and 53BP1 (F) in mock (siControl) and CHD4 depleted (siCHD4) U2OS cells treated as for (D). Graphs represent
the mean of three experiments + and - the standard deviation. (G) U2OS cells were treated with mock (siControl) or CHD4 depleted (siCHD4).
Cells were treated with 4Gy IR or unirradiated (0 hr), cell lysates were prepared at the times indicated and subjected to western blot analysis for
ATM S1981, ATM, Smc1 S957, Kap1 S824 or CHD4 as indicated.
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Figure 4 CHD4 depletion leads to increased levels of euchromatin. (A) U2OS cells were mock treated (siControl) or CHD4 depleted
(siCHD4), 48 hr following treatment the cells were detergent extracted to remove non-chromatin bound proteins prior to fixation.
Immunofluorescence analysis for Acetylated-lysine histone H4 (Acetyl-Lys-H4) and Acetylated-lysine histone H3 (Acetyl-Lys-H3) was then
performed as indicated. The merge indicates co-staining with dapi stained nuclei. (B) U2OS cells were treated with mock (siControl) or CHD4
depleted (siCHD4), 48 hr following treatment cell lysates were prepared and subjected to western blot analysis for Acetyl-Lys-H4, densitometry
was used to calculate the relative protein levels. Loading indicates a non-specific band common in each lysate. (C) 293T and HeLa cells were
mock treated (siControl), CHD4 depleted (siCHD4) or BRCA2 depleted (siBRCA2), 48 hr following treatment cell lysates were prepared and
subjected to western blot analysis for CHD4 and BRCA2 as indicated. Densitometry was used to calculate the relative levels of each protein.
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Figure 5 CHD4 chromatin association is enhanced following DNA damage. (A) HeLa cells we treated with 6Gy IR or untreated, 1 hr
following IR treatment the cells chromatin fractionation analysis was performed. Whole cell extract (WCE) and chromatin fraction lysates were
then analysed by western blot analysis with CHD4 as indicated. (B) ATM proficient (C3ABR) and ATM deficient (L3) cells we treated with 6Gy IR
or untreated, 1 hr following IR treatment the cells chromatin fractionation analysis was performed. Whole cell extract (WCE) and chromatin
fraction lysates were then analysed by western blot analysis with CHD4. (C) HeLa cells were either untransfected or transfected with plasmid
DNA encoding Flag-CHD4 or Flag-CHD4 S1349A (CHD4-A). 24 hr after transfection the cells were treated with 6Gy IR. Cells were harvested at the
times indicated and chromatin fractionation analysis was performed. WCE and chromatin fraction lysates were then subjected to western blot
analysis with CHD4. (D, E) U2OS cells were either mock transfected or transfected with siCHD4 or with plasmid DNA encoding Flag-CHD4 or
Flag-CHD4 S1349A (CHD4-A), 36 hr after transfection cells were detergent pre-extracted to remove non-chromatin bound proteins prior to
fixation. Immunofluorescence analysis for 53BP1 (D) and (E) gH2AX was then performed and the percentage of cells (+ and - standard deviation)
with multiple foci was calculated from a count of at least 100 cells across 3 independent experiments. (F) U2OS cells were transfected with
plasmid DNA encoding Flag-CHD4 (CHD4) or Flag-CHD4 S1349A (CHD4-A), 24 hr after transfection cells were treated with 2Gy IR. Prior to IR and
1 hr and 6 hr after IR, cells were detergent pre-extracted to remove non-chromatin bound proteins prior then fixed for immunofluorescence
analysis. The percentage of gH2AX positive cells (+ and - standard deviation) was then calculated from a count of at least 100 cells in 3
independent experiments.
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(wt) protein became more strongly chromatin asso-
ciated, like endogenous CHD4, however the association
of unphosphorylated Flag-CHD4-A (S1349A) did not
change (Figure 5c). These data indicate that phosphory-
lation of CHD4, following DNA damage by IR, regulates
it’s association with chromatin. This phosphorylation is
mediated by the ATM kinase and the S1349 site is
essential for this process.
We have now established that CHD4 responds to DSB
induction by IR. To determine if CHD4 is required for
DNA damage repair we next analysed the appearance of
spontaneous DNA damage in cells ectopically expressing
Flag-CHD4 and the non-phosphorylatable Flag-CHD4-A.
The ectopic expression of Flag-CHD4 had no effect on
the number of gH2AX positive cells in the population,
interestingly neither did the depletion of CHD4 (siRNA)
which support the enhanced DNA repair phenotype
observed earlier in this study. However, the ectopic
expression of Flag-CHD4-A significantly increased the
percentage of cells showing spontaneous (undamaged
cells) gH2AX and 53BP1 foci (Figure 5de) suggesting that
these cells had impaired ability to cope with endogenous
DNA damage.
To further explore this we next treated HeLa cells
with low dose IR (2Gy) to determine the repair kinetics
of DSBs. To do this, we analysed the ability of HeLa
cells expressing wt and phospho-mutant CHD4 to
resolve gH2AX foci. Maximal gH2AX foci were observed
in both wt-Flag CHD4 and Flag-CHD41349A mutant
expressing cells at 1 h after irradiation. In wt-CHD4
transfected cells, gH2AX foci were present in ~ 7% of
cells by 6 h after damage (Figure 5f). In contrast, Flag-
CHD41349A mutant expressing cells were slower at
resolving the gH2AX foci and retained gH2AX foci in
~20% of cells by 6 h which returned to predamage level
24 h after IR. These data indicate the phosphorylation
of CHD4 at Ser 1349 is required for the efficient repair
of double strand DNA breaks.
Discussion
It is important to understand how cells respond to and
attempt to repair double strand DNA breaks. Much is
already known in regard to the recruitment of repair
factors and the checkpoint activation pathways, however,
it is becoming increasingly clear that chromatin remo-
deling must take place to allow efficient repair. CHD4
has previously been characterized as a component of the
NuRD transcriptional repression complex [15,30] that
exists as a part of a complex with ATM-related kinase
ATR [31].
Here we identified CHD4, as an ATM interacting pro-
tein and subsequently showed that it is a direct target of
ATM kinase. CHD4 is phosphorylated on Ser1349
in vivo in cells in an ATM dependent manner in
response to IR. During the course of our study, another
study reported CHD4 as a phosphorylation target of
ATM kinase that supports our findings [13]. This study
reported that association of CHD4 with DNA lesions
occurs independently of ATM instead the authors found
that it is dependent on poly (ADP-ribose) specific path-
way. Another study reported significant enrichment in
chromatin binding of CHD4 in response to IR, which
could be explained in part by its retention directly at
the sites of DNA damage [17]. Consistent with this
report, we also observed ATM-dependent increase in
chromatin retention of CHD4 after IR. Moreover, we
found that Ser1349 phosphorylated CHD4 accumulated
into IR-induced foci which colocalize with gH2AX,
while staining with antibody that detects the total pool
of CHD4 remained unchanged in response to IR sug-
gesting that phosphorylated CHD4 might play a role in
the regulation of DNA repair processes. Although
CHD4 is not an essential component of the repair pro-
cess, our data demonstrates that CHD4 functions to
allow the timely repair of DNA damage, which is
essential to maintain cellular viability. Consistent with
this, CHD4-depleted cells show an elevated level of
recruitment of DNA repair factors to chromatin fol-
lowing DNA damage. This however may be due to the
general opening of the chromatin structure in cells
depleted of CHD4, which would allow more rapid
recruitment and would also result in elevated levels of
DNA damage. Indeed, we demonstrate that markers
of euchromatin increase significantly in cells depleted
of CHD4 and there are large cellular changes in the
transcriptome. This supports a general role of CHD4
and the NuRD complex in regulating global chromatin
structure and expla!ins theglobal impact of CHD4
depletion.
To explore the possible role of CHD4 in DSB repair
further we decided to study the role of the ATM
mediated phosphorylation of CHD4 on Ser1349. Follow-
ing IR treatment, CHD4 becomes more tightly chroma-
tin associated in an ATM dependent manner, which
might help localize CHD4 in close proximity to DNA
lesions. It is likely that ATM modifies the cellular func-
tion of CHD4 specifically at sites of DSBs since DNA
damage is known to cause retention of active ATM
kinase in detergent-resistant nuclear fractions [32]. Cells
ectopically expressing Flag-CHD4-A, which cannot be
phosphorylated by ATM, fail to show enhanced chroma-
tin retention after IR suggesting that ATM dependent
phosphorylation might result in CHD4 becoming more
tightly associated with the chromatin and this allows
for the opening of the chromatin structure and repair.
Consistent with this, cells ectopically expressing ATM-
phosphosite mutant CHD4 (Flag-CHD4-A) displayed
higher rates of spontaneous DNA damage and showed a
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defect in their ability to resolve IR induced gH2AX foci
in a timely manner.
Collectively, our data demonstrates how phosphory-
lated CHD4 functions to facilitate the repair of DSBs.
Understanding the cellular processes that control chro-
mosomal stability are of vital importance. Our data pro-
vides evidence that CHD4, a component of NuRD
complex is required to allow the timely repair of breaks
and provide further support to the idea that there is an
intimate link between ATM kinase and chromatin
remodelling complexes involved in different aspects of
chromatin dynamics in mammalian cells. Therefore, dis-
secting the interplay of ATM kinase and chromatin
modifying activities has become a vital step towards
understanding of DNA damage response. This data
gives us interesting insight into the function chromatin
remodelers may play in modulating the effect of che-
motherapeutic drugs [33]. Furthermore, therapies that
target the chromatin modifying enzymes are being
investigated for the treatment of cancer [34,35].
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